Selective late steroid withdrawal after renal transplantation

Pediatric Nephrology

Volumn 22, Issue 11, 2007, Pages 1947-1952

  Laube, Guido F ^a   Falger, Jutta ^a   Kemper, Markus J ^a   Zingg Schenk, Andrea ^a   Neuhaus, Thomas J ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Growth; Rejection; Renal function; Renal transplantation; Steroid withdrawal

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; AZATHIOPRINE; BASILIXIMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; PREDNISONE; STEROID; TACROLIMUS;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; ASEPTIC NECROSIS; B CELL LYMPHOMA; BODY HEIGHT; BODY MASS; BONE DISEASE; CATARACT; CLINICAL ARTICLE; DIARRHEA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIPHYSIOLYSIS; EYE DISEASE; FEMALE; FOLLOW UP; FRACTURE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LOW DRUG DOSE; MALE; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SURVIVAL RATE; VISUAL ACUITY;

ADOLESCENT; ADOLESCENT DEVELOPMENT; AZATHIOPRINE; BLOOD PRESSURE; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STEROIDS;

EID: 34848924290     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0576-1     Document Type: Article

References (26)

1. Tonshoff B, Mehls O (1997) Factors affecting growth and strategies for treatment in children after renal transplantation. Pediatr Transplant 1:176-182
2. Acott PD, Crocker JF, Wong JA (2003) Decreased bone mineral density in the pediatric renal transplant population. Pediatr Transplant 7:358-363
3. Vidhun JR, Sarwal MM (2005) Corticosteroid avoidance in pediatric renal transplantation. Pediatr Nephrol 20:418-426
4. Oberholzer J, John E, Lumpaopong A, Testa G, Sankary HN, Briars L, Kraft KA, Knight PS, Verghese P, Benedetti E (2005) Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients. Pediatr Transplant 9:456-463
5. Ellis D (2000) Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants. Pediatr Nephrol 14:689-694
6. Motoyama O, Hasegawa A, Ohara T, Satoh M, Shishido S, Honda M, Tsuzuki K, Kinukawa T, Hattori M, Ito K, Ogawa O, Yanagihara T, Saito K, Takahashi K, Ohshima S (2005) A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: Results obtained between 1990 and 2003. Pediatr Transplant 9:232-238
7. Chakrabarti P, Wong HY, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Hakala TR, Fung JJ, Simmons RL, Starzl TE, Shapiro R (2000) Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 70:760-764
8. Jensen S, Jackson EC, Riley L, Reddy S, Goebel J (2003) Tacrolimus-based immunosuppression with steroid withdrawal in pediatric kidney transplantation-4-year experience at a moderate-volume center. Pediatr Transplant 7:119-124
9. Hocker B, John U, Plank C, Wuhl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tonshoff B (2004) Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: Results after four years. Transplantation 78:228-234
10. Silverstein DM, Aviles DH, LeBlanc PM, Jung FF, Vehaskari VM (2005) Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients. Pediatr Transplant 9:589-597
11. Sarwal MM, Yorgin PD, Alexander S, Millan MT, Belson A, Belanger N, Granucci L, Major C, Costaglio C, Sanchez J, Orlandi P, Salvatierra O Jr (2001) Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 72:13-21
12. Pascual J, Quereda C, Zamora J, Hernandez D (2005) Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil. Transplant Proc 37:3746-3748
13. Klaus G, Jeck N, Konrad M, Forster B, Soergel M (2001) Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity. Clin Nephrol 56:S37-S42
14. Sarwal M (2006) Steroid elimination is coming of age. Pediatr Nephrol 21:2-4
15. Marks SD, Trompeter RS (2006) Steroid preservation: The rationale for continued prescribing. Pediatr Nephrol 21:305-307
16. Tönshoff B, Offner G, Hoecker B, Pape L, Rascher W, Neuhaus T, Hoppe B, Querfeld U, Bulla M, Klaus G, Latta K, Leichter H, Fehrenbach H, Wygoda S, Misselwitz J, Montoya C, Mueller-Wiefel D, Foulard M, Hoyer P, Cochat P, Fischer W, Zimmerhackl LB (2006) A multicenter, placebo-controlled trial evaluating the efficacy and safety of Basiliximab (Simulect) in combination with CsA, MMF and steroids in pediatric renal allograft recipients: 12 months results. Pediatr Nephrol 21:1513 (abstract)
17. Chantler C, Barratt TM (1972) Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child 47:613-617
18. National High Blood Pressure Education Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (2 Suppl):555-576
19. Mitsnefes MM, Khoury PR, McErny PT (2003) Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143:98-103
20. Prader A, Largo RH, Molinari L, Issler C (1989) Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52:1-125
21. Cattaneo D, Perico N, Gaspari F, Gotti E, Remuzzi G (2002) Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kidney Int 62:1060-1067
22. Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K (2005) Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 80:1233-1243
23. Mitsnefes MM (2004) Hypertension and end-organ damage in pediatric renal transplantation. Pediatr Transplant 8:394-399
24. El-Husseini AA, Foda MA, Shokeir AA, Shehab El-Din AB, Sobh MA, Ghoneim MA (2005) Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: A single center experience. Pediatr Transplant 9:763-769
25. Watson AR (2000) Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 14:469-472
26. Neu AM (2006) Special issues in pediatric kidney transplantation. Adv Chronic Kidney Dis 13:62-69